Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

@article{Huang2020ClinicalFO,
  title={Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China},
  author={C. Huang and Yeming Wang and X. Li and L. Ren and Jianping Zhao and Y. Hu and L. Zhang and Guohui Fan and J. Xu and Xiao-ying Gu and Zhen-Shun Cheng and T. Yu and Jia'an Xia and Yuan Wei and Wen-juan Wu and Xuelei Xie and Wen Yin and H. Li and M. Liu and Y. Xiao and H. Gao and L. Guo and J. Xie and G. Wang and R. Jiang and Zhancheng Gao and Qi Jin and J. Wang and B. Cao},
  journal={Lancet (London, England)},
  year={2020},
  volume={395},
  pages={497 - 506}
}
  • C. Huang, Yeming Wang, +26 authors B. Cao
  • Published 2020
  • Medicine
  • Lancet (London, England)
  • Summary Background A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods All patients with suspected 2019-nCoV were admitted to a… CONTINUE READING
    12,363 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    There is a high risk of transmission of COVID-19 to healthcare workers. In a recent cohort, 29% of the patients hospitalized were healthcare workers. Among the WHO's primary strategic… Expand
    ConditionsCoronavirus, Oxygen Toxicity, Pneumonia
    InterventionDevice, Other
    INTERVENTIONAL CLINICAL TRIAL
    The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating 2019-nCoV infection. After the enrolment of approximately 30 subjects… Expand
    ConditionsPneumonia Caused by Human Coronavirus (Disorder)
    InterventionDrug
    INTERVENTIONAL CLINICAL TRIAL
    Research Background and Rationale In December 2019, a new infectious respiratory disease emerged in Wuhan, Hubei province, China. An initial cluster of infections was linked to… Expand
    ConditionsCOVID-19
    InterventionCombination Product, Other
    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to evaluate the efficacy and safety of ruxolitinib in the treatment of patients with COVID-19 severe pneumonia.  
    ConditionsARDS, Human, COVID
    InterventionDrug
    Clinical features of 2019 novel coronavirus infection in Beijing.
    • 1
    • Highly Influenced
    Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
    • 494
    • Highly Influenced
    • PDF
    Clinical Characteristics of Coronavirus Disease 2019 in China
    • 8,467

    References

    SHOWING 1-10 OF 49 REFERENCES
    Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
    • 3,064
    • PDF
    A major outbreak of severe acute respiratory syndrome in Hong Kong.
    • 1,763
    A novel coronavirus associated with severe acute respiratory syndrome.
    • 3,091
    • PDF